chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dx Nasal Congestion  ? Sore Throat ? loss of senses  ? Shortness of Breath  ? Cough ? Headache
Drop in blood pressure (92/58), nausea, dizziness, tingling in hands and feet, trouble breathing through a mask, lightheaded, unable to sit up. Symptoms were similar to how an adverse reaction to my food allergy starts.
Right arm was numb and tingling.; Right arm was numb and tingling; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6955) via an unspecified route of administration in the left arm on 03Apr2021 at 12:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, obesity and allergies to apples, bananas and avocados. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included doxylamine (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 12Mar2021 at 12:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. On 04Apr2021, at 08:00 in the morning the patient's right arm was numb and was tingling which lasted for the whole day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events right arm was numb and tingling were recovered on 04Apr2021.
102 Degree fever started 6 hours after injection. Fever continued for 36 hours, extreme pain in arm and exhaustion for about 5 days. Swollen arm at site.
Pt developed rash and swollen lymph nodes in the back of her neck and shoulder and left under arm and fever for almost 2wks now and no improvement.
no additional AE reported; HCP reported patient received a fourth dose of Gardasil 9. HCP stated dose number three was received twice; This spontaneous report has been received from a nurse, regarding a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concomitant medications, concurrent conditions and previous drug reactions or allergies were unknown.  On 20-OCT-2021, the patient was vaccinated with the fourth (4th) dose of hpv rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) at a dose of 0.5 milliliters (mL) as prophylaxis (lot number U007477 verified as valid, expiration date reported and stablished as 14-APR-2023) (route of administration and anatomical location of vaccination); the nurse reported that the patient received the third dose twice (extra dose administered). No additional adverse event (AE).
Patient received two doses of Moderna mRNA vaccine.  Patient then tested positive for COVID-19 on 10/4/21 and required inpatient admission from 10/4/21 to 10/18/21 requiring supplemental O2. He was well enough for discharge on 10/12 but longer stay was necessary due to placement issues.
Knot at injection site; Arm became very sore; This is a spontaneous case, reported by other non-health professional (consumer) to Company [reference number: SEQ19-07192] and initially received on 03-Dec-2019, concerning a female patient of unspecified age. At the time of this report the patient was 77-year-old.   The patient's relevant medical history was not reported. The patient's concomitant medications were not reported.  On an unspecified date, the patient was administered with unspecified Flu Vaccine [Influenza virus vaccine; dose, anatomical location, route of administration, batch number and expiration date: not reported] for an unknown indication.  On an unspecified date, an unknown amount of time after vaccination, the patient's arm became very sore and she developed a knot at the injection site.  On an unspecified date, the patient recovered from the event of vaccination site lump.  At the time of this report, the outcome for the event of pain in arm was not reported.  The case was assessed as non-serious.  The reporter assessed the events to be related to Flu vaccine.   The patient did not provide consent to be contacted for further follow up.  Company comment: Patient developed adverse events after vaccination, however latency interval is unknown. As no alternative aetiology was reported, both events are assessed as related to an unspecified Flu vaccine.; Sender's Comments: Patient developed adverse events after vaccination, however latency interval is unknown. As no alternative aetiology was reported, both events are assessed as related to an unspecified Flu vaccine.
Fever, Chills, Aches, Diarrhea, Cough. I currently still have all symptoms the next day at 9:45am after the vaccine.
Right sided mild facial swelling, left side facial droop-eye, corner of mouth, decreased forehead creases, loss of nasolabial fold and impaired speech.Treatment includes Acyclovir 400mg orally five times a day, Prednisone 10mg orally daily, Lacri-lube S.O.P. ophthalmic ointment to left eye at bedtime. Patient was to follow-up in 1 week.  At follow-up patient continued to have left sided facial droop, feels like his left nostril is "closed", left ear feels full, swelling to left neck and shoulder. Provider plan to continue current medications and continue facial exercises.  Follow-up set for 1 month.
Information regarding PREVNAR 13 was received from a healthcare professional regarding a 6-month-old female patient who experienced exacerbation of eczema. At 6 months of age, the patient received the first dose on 25-May-2010. The patient also received the third dose of ROTATEQ (Merck & Co Inc) and the third dose of PENTACEL (Aventis-Pasteur) on 25-May-2010. On 10-Jun-2010 the patient experienced exacerbation of eczema. The patient was seen by the dermatologist. The patient recovered. See related case(s): US-WYE-H17059810 (adverse event, non-expedited) for the same event following PREVNAR administration at 4 months of age. No additional information was available at the time of this report.
pt recv vax & w/in 1min fell to ground, sl jerking motion of upper & lower extremities noted x 3-5 seconds;following episode BP 120/70, P60, R slow;eyes gazed, pale in color, skin clammy;moves extremities on command;lightheadedness;
NO ADVERSE EVENTS. I failed to check the patient's past covid vaccine record (PFIZER 3 TIMES at different location---- 3/15/21, 4/15/21, 10/08/21) and I gave Novavax 1st dose on 7/28/22 without knowing.  The patient states that he has been waiting for Novavax for a long time and seems to be naive to any covid vaccine.  No adverse events but I decided to report this Novavax to be used like a booster by patient own.
has an adverse event to report; A spontaneous report was received on 26 Jan 2021, from a Healthcare Professional concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: UNKNOWN) intramuscularly for prophylaxis of COVID-19 infection.   On an unknown date, the patient experienced the event has an adverse event to report.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, has an adverse event to report was not reported.; Reporter's Comments: Very limited (NO) information regarding this event has been provided at this time.  Further information has been requested.
Patient was given a dose of Moderna vaccine when her first dose was a Pfizer vaccine. Patient displayed no adverse signs and symptoms and was educated about not receiving an additional dose.
This consumer report (initial receipt 16-Jan-2014) concerns a 20 year old female patient. On the 23-Dec-2013, the patient received AFLURIA (batch number '1253807') 0.5 mL one dose on the left side via an intramuscular injection. Immediately after being administered AFLURIA, the patient developed soreness at the injection site. One day after administration, she experienced severe shoulder and neck pain on the left side of her body (the same side AFLURIA was administered), sharp pains in her left arm and she could not move her neck for three weeks. She visited her primary care physician. Treatment included MOTRIN and VICODIN. On the 15-Jan-2014, she visited a neurologist. She also visited a chiropractor. Outcome was reported as recovering.
Reported hive like rash that started lasted night. Also had flu vaccine on Tues (10/9/18) - hospital is submitting VAERS on that. Patient also reported/stated she had a rash after her 1st HPV, but she was also on antibiotics at the time.
On Feb 4, 2022 I had pain in my left calf. It did not go away
states that the next day she experienced "a little bit" of chills and achiness but that it went away; states that the next day she experienced "a little bit" of chills and achiness but that it went away; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 83 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Mar2021 (Lot number: EN6203) at the age of 83 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "COPD", start date: 24Mar2021 (ongoing); "Blood pressure" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Pneumonia shot (In early February 2021/ late January 2021. had some swelling and itchiness after pneumonia shot. patient took Benadryl and went away.); Covid-19 (Lot Number : EM9809, for the first dose.). The following information was reported: PAIN (non-serious) with onset 16Mar2021, outcome "not recovered", CHILLS (non-serious) with onset 16Mar2021, outcome "recovered" and all described as "states that the next day she experienced "a little bit" of chills and achiness but that it went away". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain, chills.  Additional Information: The report type is initial and not related to study programme. The patient was the reporter. NDC and expiry date of COVID-19 vaccine was unknown. The patient was not taking other medications. The patient was diagnosed ages ago, but her blood pressure is under control. Patient confirms this condition has been ongoing for 25 years at least and Investigation Assessment was done. The patient had first covid vaccine provided with a lot number. The patient takes her usual blood pressure medication and a breathing medication for COPD, but has been taking these for a long time. It was unknown that History of all previous immunization with the Pfizer vaccine considered as suspect. Patient has no NDC, Lot number or expiry date for the pneumonia shot. Patient had no illness at the time of vaccination. No information on Family Medical history relevant to adverse event was provided. Patient had a checkup at the doctor office this week and they drew blood to check cholesterol and stuff like that All labs were good.  No follow-up attempts are possible. No further information is expected.
HALF OF PATIENTS UPPER LIP SWELLED UP THE DAY AFTER THE 2ND VACCINE WAS ADMINISTERED THEN FULL UPPER LIP WAS SWOLLEN THE FOLLOWING DAY . PATIENT WAS TOLD TO GO TO URGENT CARE OR PCP IF ISSUES DOESNT RESOLVE, SPREADS TO OTHER AREAS OF THE FACE OR OTHER AREAS OF THE BODY BEGIN TO SWELL.
We were told to report this incident to Vaers in reference to  not qualifying for the booster shot. Pt claimed he had emphysema, which is not a qualifying condition
Fever; Chills; Product supply issue; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 74-year-old male patient who received Herpes zoster (Shingrix) (batch number N9CA2, expiry date 2nd July 2021) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced fever, chills and product supply issue. On an unknown date, the outcome of the fever, chills and product supply issue were unknown.   It was unknown if the reporter considered the fever and chills to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not applicable for the 2nd dose. The pharmacist called in to report that he had a couple come in greater than 6 months before the reporting date to receive first Shingrix immunization.  The 2nd dose was unavailable till the time of reporting.  This case has been linked with US2019081362, reported by same reporter.
diarrhea started 2 days after vaccine and continued on and off for about 1.5 weeks. A covid test was done and negative
Varicella infection; This case was reported by a pharmacist via call center representative and described the occurrence of varicella in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced varicella. On an unknown date, the outcome of the varicella was unknown.   It was unknown if the reporter considered the varicella to be related to Shingrix.  Additional details were provided as follows:  The age at vaccination was not reported. The pharmacist reported that the patient developed chickenpox after receiving the 1st dose of Shingrix.  The health care professional declined to provide any further information at the time of reporting.
Giant baseball size now above injection site. Plus swollen lymph nodes under my arms. Painful . Persisted for the last 5 days.
headache and sees blocks, called dr who asked mom to take to E.R. She was evaluated in E.R. with no finding and treatment and sent home. She is doing well according to her mom.
Slight discomfort in left arm injection site by 6PM and went to bed 9:30PM.  Woke up 12:30AM with chills and did not sleep well for the remainder of night.  Got up 5:30AM ate something and had some coffee.  What was noticeable  initially was fatigue, followed by chills.  My temperature was 99.2 and 99.4.  I never took any medication until going to bed. I reported in sick to work and went back to bed for 4 hours approximately.  I felt bad all day even as I went to bed.(chills and very fatigued).  I tried to keep very warm and took Tylenol PM to sleep. 100% recovery 1 day later
That night, eyes turned in, seizures, muscle spasms that lasted for 5 days. When they called the hospital, they told not to bring the baby in unless there was a high fever. Took baby to the doctor on Monday, showed her the videos; she did not think anything was wrong. Checked with his colleagues, told her that is was normal. Took patient to doctor 2 months later and was referred to eye surgeon.  Surgeon wanted to have surgery immediately but parents refused. Patient stills sees eye doctor until today. After 6 months, parents left the practice and went to new doctor. So far, parents have only received a referral to eye doctor, but no testing or prescribed medication. Parent has plenty of photos and videos about spasms and seizures to share as needed. Last doctor visit was on October 4th.    Received 18 month vaccines on 1/23/18.
Redness, swelling, pain at injection site. Spread from shoulder to elbow. Also had headache, nausea, vomiting, diarrhea, fatigue for 2-3 days following vaccine admin. Pt. recovered at home.
Four days after receiving my second dose of the Pfizer Covid-19 vaccine, I awoke with diffuse abdominal pain and was admitted to the emergency room at local Hospital. I was diagnosed with appendicitis and underwent immediate surgery.  The surgery was successful and I spent one night in the hospital. My recovery was normal and I have no prolonged symptoms from either the vaccine or the surgery. Recently I read about a statistically significant increase in the number of cases of appendicitis following Covid-19 vaccinations, which prompted me to report my case. Because the time between my second dose and the onset of symptoms was under 5 days, I felt it would be best to report it.
Nausea Dizziness Lightheadedness Dehydration Systolic hypotension Afebrile Syncope without collapse Tachycardia Anxiety Anxiety attack Panic attack Tachypnea Pain upon palpation at site Erythema at site Swelling at site Muscle pain at site that lasted for 3 weeks Weakness that lasted for 7 hours
Eye stroke--central retinal vein occlusion (CRVO) right eye Vision loss Eye Pain Monthly eye injections (Aflibercept/Eyelea) projected for more than 12 months
Employee was given a flu shot 11/29/21. He came in requesting flu shot, filled out a written consent, discussed with me he was here for flu shot, I went through written consent with him and administered the above flu vaccine. When I was giving him his flu vaccine sticker for his name badge I noticed he had one that stated 2021/2022.  When I questioned him he said I thought this was a Covid booster.  When I reviewed his online employee health chart I saw he received a flu shot on 9/29/21.
accidently gets 3 doses of shingrix; This case was reported by a other health professional via call center representative and described the occurrence of circumstance or information capable of leading to medication error in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced circumstance or information capable of leading to medication error. On an unknown date, the outcome of the circumstance or information capable of leading to medication error was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The physician's assistant asked if there were there any negative effects if a patient accidently gets 3 doses of Shingrix.  The reporter had a patient who insisted that he had only one dose and so he wanted a 2nd dose and they showed him a record of already receiving 2 doses, which was the circumstance or information capable of leading to medication error since there was a possibility of either an extra dose or possible underdose (inappropriate schedule). The reporter consented to follow up via email but declined to leave patient's initials
Patient began itching all over his body. The patient has been taking Benadryl to alleviate symptoms. Patient still reports occasional itching. No other symptoms.
9/25/22 Symptom onset with nausea and vomiting 9/27/22 Symptoms worsen. ER visit: n/v, fever, chills, h/a. IV fluids, zofran, tylenol given. ER discharge home. Diagnosis: N/V, hyponatremia, headache, fever. RA 9/29/22 Hospital Admit. Worsening symptoms. Fatigue, weakness, low grade fever, nausea, feeling balance off.  Out of range labs: platelet drop from 102 to76. WBC 3.34. H&H 13.4/39.4 to 10.8/31.2. UA+2bilirubin/+2protein/+2urobilinogen.  10/1/2022 Due to worsening symptoms/lab findings patient transferred to higher level care hospital.  Admit Diagnosis: febrile illness likely secondary to immune reaction from recent Influenza and Covid Booster vaccinations thrombocytopenia transaminitis hyponatremia Treatment: IV fluids. Solu-Medrol transistioned to oral prednisone. Patient improved with treatment and discharged home 10/3/22. 10/4/22 Spoke with patient: continued weakness and not feeling herself yet. F/U apts with PCP
From telephone contact received at manufacturer on 06/24/2002 regarding 3 patients who received Tripedia vaccine (lot #U0532AA), IPOL (lot #T12942-2) and Prevnar on 04/05/2002. The mother of the 3 patients called to report that all 3 of her children had reactions to vaccines administered. She reported that one month later all 3 had seizure like activity, high fever and screaming and shaking. Twins and another younger baby. She reported that she could not awake the youngest all night. Twins also slept unusually long. One twin on 05/13/2002 was limping and taken to the ER, had an ear infection, and on 05/16/2002 had spell in high chair which mom said he was unconscious for 1 hour. Other twin on 05/18/2002 had a seizure. She still awakes at night screaming and shaking. Youngest still has shakes and tremors. A neurologist has evaluated them all and attributes to immature immune systems. Linked with cases: U2002-00475 and U2002-00476.
Sense of smell affected (I don?t have COVID, I previously had it two months ago)
Pruritus lasting 3 wks; swelling, pain, difficulty with lifting the arm lasting 7 weeks post intradermal injection. 7 wks post still c/o pain R.U. arm.
2 1/2 year old received an adult dosage influenza vaccine. Nurse was distracted by sibling who was crying and thought he was getting a shot. Nurse was trying to reassure him it wasn't for him, but for sister. Nurse then grabbed adult vaccine and administered to the toddler. After administering it, nurse realized what happened. Informed mother of toddler what occurred. Nurse immediately notified provider. Provider then went in to talk to mother of possible risks and would follow up with CDC recommendations.
The patient experienced what appeared to be a seizure. She had involuntary muscle contractions and loss of consciousness for roughly 30 seconds.
Approx one month after vaccination, member found down in room. He was couple days post op from wisdom teeth extraction surgery. He was taken to local hospital and found to be in DKA (no prior dx of diabetes), Acute renal failure, COVID-19 positive. He remains in ICU in critical condition.
Had us down; This case was reported by a consumer via interactive digital media and described the occurrence of feeling unwell in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was recovered/resolved.   It was unknown if the reporter considered the feeling unwell to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The shot had put down the patient for 12 hours.  The patient was fine now. The follow up would not possible as no contact details were available. The case had been linked to US2022AMR046615, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR046615:Same reporter.
pt recvd vax & 25AUG95 pt devel blistering red rash, & itching;there was no fever; presented to MD, lab eval revealed varicella IgG antibodies & varicella culture to be neg 27SEP95;
Received JJ vaccine March 10, 2021.   On March 23rd, when waking, a severe pain in lower right abdominal quadrant and right hip area began to occur. Pain continued thru several days, went to walk in clinic and they referred to ER. Primary care provider too far to drive safely.   Pain ranged from 3 to 5 with intense burning, stabbing or spasm.  Had only taken Tylenol at home before finally going to seek care.  CT scan and labs completed.  Determined to be muscle strain.  Pain medication did not relieve symptoms.   Applied ice and heat treatment with nsaids and flexerill.  75% improved by March 29th.  Saw pcp on April 9th. Scheduled to have ultrasounds this April 16th.  Pain is only level 2 every  other day and lasts maybe 2 hours.